In conclusion, this study identified that targeting ATR using ceralasertib enhances the antitumour activity of RT through the induction of DNA damage in PTEN-depleted NSCLC cells, with the addition of ceralasertib having a minimal effect on inflammatory cell infiltration indicative of RP in comparison to radiation exposure alone. The gene discussed is ATR; the disease is non-small cell lung carcinoma.